Panelist
speaker
Moderator
conference Team

Sam A. Beeler

Chief Strategy Officer, Nebula Genomics
Sam A. Beeler

Christian Happi, is a Distinguished Professor of Molecular Biology and Genomics, and Director of Institute of Genomics and Global Health, Redeemer’s University, Ede, Nigeria.

He did his postdoctoral fellowship at Harvard University (2000-2003), and worked there as a Research Scientist (2004-2007). He is currently Adjunct Professor in the Department of Immunology and Infectious Diseases, Harvard T H Chan School of Public Health, Boston, USA. 

Professor Happi used next generation sequencing technology to perform the first sequence of the SARS-CoV-2 in Africa, within 48 hours of receiving sample of the first case in Nigeria. This seminal work not only provided an insight into the detailed genetic map of the coronavirus in Africa, but also paved the way to the development of new countermeasures including new diagnostics, therapeutics and vaccines.

He received the Merle A. Sande Health Leadership Award (2011); the 2019 Human Genome Organization Africa Prize for his seminal work on infectious diseases genomics in Africa; the 2020 Bailey K. Ashford Medal by the American Society of Tropical Medicine and Hygiene. In 2021, he received the Al-Sumait Prize for African Development of the Kuwait Foundation for Advancement in Sciences. He is a Fellow of the Nigerian Academy of Sciences, A Fellow of Academy of Medical Specialties of Nigeria, and he is a member of the US National Academy of Medicine.

Agenda

More Info
Breakout 3
|
Saturday
|
3:45 pm
Aldrich 107
Unlocking the African Genome: Positioning the Continent as the Next Hub for Genomic Innovation
This panel explores Africa’s genomic potential, biotech leadership, and ethical funding for equitable healthcare advances.
More Info

Unlocking the African Genome: Positioning the Continent as the Next Hub for Genomic Innovation

The African genome, one of the most genetically diverse yet understudied, holds immense potential to transform global healthcare. As the cradle of human life, Africa’s genetic diversity is key to understanding the foundations of humanity. Unlocking its secrets could lead to breakthroughs in disease treatments, drug development, and personalized medicine. However, realizing this potential will require significant financial investment, capacity building, and robust ethical frameworks to ensure Africa benefits from these advancements while preventing exploitation.

This panel seeks to answer the following questions: How can understanding the African genome save lives globally? How can Africa become a biotech leader in the genomic era? And crucially, what innovative funding models can be developed to support genomic research in Africa while ensuring equitable returns for African communities?

America/New_York
Feb 15, 2025 3:45 PM
Aldrich 107